Lazard Asset Management’s Lifestance Health LFST Stock Holding History

Lazard Asset Management’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$485K	Sell	76,066 -11,596	-13%	-$80.7K	﹤0.01%	1393
2025 Q4	$617K	Buy	87,662 +38,693	+79%	+$233K	﹤0.01%	1307
2025 Q3	$269K	Buy	+48,969	New	+$240K	﹤0.01%	1522
2024 Q2	–	Sell	-4,957	Closed	-$30K	–	2347
2024 Q1	$30K	Hold	4,957	–	–	﹤0.01%	1803
2023 Q4	$38K	Hold	4,957	–	–	﹤0.01%	1959
2023 Q3	$34K	Buy	4,957 +2,681	+118%	+$21.7K	﹤0.01%	1966
2023 Q2	$20K	Buy	+2,276	New	+$18.9K	﹤0.01%	2101

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SPIG

Silversmith Partners I GP Boston, Massachusetts $39.2M AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Lazard Asset Management's LFST Position: Q1 2026 in Review

Lazard Asset Management reduced its Lifestance Health (LFST) stake by 13% in Q1 2026, selling an estimated $80.7K and leaving 76,066 shares worth $485K. The position accounts for ﹤0.01% of the portfolio, ranked #1393.

Lazard Asset Management first reported a position in LFST in Q2 2023 and has held it in 7 quarters since. The position peaked at $617K in Q4 2025. 228 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

Lazard Asset Management held 76,066 shares of Lifestance Health worth $485K as of Q1 2026.
Lazard Asset Management sold 11,596 Lifestance Health shares in Q1 2026, an estimated $80.7K.
Lifestance Health made up ﹤0.01% of Lazard Asset Management's portfolio in Q1 2026, its #1393 holding.
Lazard Asset Management first reported a position in Lifestance Health in Q2 2023 and has held it in 7 quarters since.
Lazard Asset Management's Lifestance Health position peaked at $617K in Q4 2025.
228 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.